title: Vascular drugs in the new millennium.
authors.affiliation: Section of Vascular Surgery, Yale University School of Medicine, New Haven, CT 06510, USA.
authors.forename: S G
authors.initials: SG
authors.lastname: Frangos
authors.forename: A H
authors.initials: AH
authors.lastname: Chen
authors.forename: B
authors.initials: B
authors.lastname: Sumpio
mesh_terms: D000077284:Abciximab; D000818:Animals; D016255:Anistreplase / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D002809:Chondroitin Sulfates / Q000627:therapeutic use; D000077144:Clopidogrel; D003871:Dermatan Sulfate / Q000627:therapeutic use; D004338:Drug Combinations; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006497:Heparan Sulfate / Q000627:therapeutic use; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D007383:Intermittent Claudication / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013300:Streptokinase / Q000627:therapeutic use; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014652:Vascular Diseases / Q000188:drug therapy*; D020246:Venous Thrombosis / Q000188:drug therapy
chemical_list: D000077284:Abciximab; D016255:Anistreplase; D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D001241:Aspirin; D002809:Chondroitin Sulfates; D000077144:Clopidogrel; D003871:Dermatan Sulfate; D004338:Drug Combinations; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D006497:Heparan Sulfate; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D013300:Streptokinase; D013988:Ticlopidine; C035838:danaparoid